Tech Company Financing Transactions
Naveris Funding Round
Naveris, based in Natick, secured $33.4 million in investment from Gurnet Point Capital, BrightEdge and TechU Angels.
Transaction Overview
Company Name
Announced On
9/19/2022
Transaction Type
Venture Equity
Amount
$33,400,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from this financing will be used to advance commercialization of NavDx, Naveris' flagship blood test for the early detection of cancers caused by the human papillomavirus (HPV), and to generate the clinical data needed to expand into other cancer types and indications.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
22 Strathmore Rd.
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Website
Email Address
Overview
Naveris, Inc. is a molecular diagnostics company developing and bringing to market novel blood tests to enhance the early detection and clinical management of viral-associated cancers. The company has developed the NavDx test, which uses proprietary technology to detect tumor tissue modified HPV.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Piyush Gupta
Chief Medical Officer
Barry Berger
Chief Scientific Officer
Phillip Stephens
Co-Founder
Philip Haydon
VP - Finance
Thomas Liem
Browse more venture capital transactions:
Prev: 9/19/2022: 1MRobotics venture capital transaction
Next: 9/19/2022: Alphyn Biologics venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs